Agreement on a far-reaching trade accord eluded negotiators for a dozen Pacific Rim nations on Saturday as the US and Australia remained divided over commercial protections for drug companies, leaving tired and testy trade ministers to agree to a last round of talks yesterday.
The impasse over protections for advanced brand-name drugs prompted negotiators to put off settling a separate dispute over dairy exports. So the two issues, drugs and dairy products, became the final obstacles to concluding the largest regional trade agreement in history, the Trans-Pacific Partnership (TTP), after seven years of talks.
The long-simmering drug debate concerns biologics, advanced medicines derived from living organisms and believed to hold promise in treating cancer.
The US and the pharmaceutical industry, not typically a US President Barack Obama administration ally, have fought for companies to have exclusive rights to their research data for an extended period before the information is released and can be used to produce less costly generics. They argue that such protection is needed to give companies a financial incentive to innovate and produce new drugs.
The US reduced its demand to eight years of exclusive data rights from the level in federal law, which is 12 years, but that was still too long for Australia and its allies, including Chile, New Zealand, Peru and Malaysia. Those nations’ laws allow zero to five years of monopoly protection.
On their side are the generic-drug industry and some non-profit organizations that support speeding affordable drugs to the market as quickly as possible.
Representatives for Doctors Without Borders, which has medical operations in up to 70 mostly poor nations, worked the halls at the hotel here where negotiators have been meeting behind closed doors since Wednesday.
“The main goal of the industry,” Judit Rius Sanjuan said, is “to deny generic competition and make prices higher.”
On the dairy issue, Canada, in particular, was pitted against the US and New Zealand, among others. The matter is especially sensitive for Canada because it holds federal elections in less than two weeks. Its agriculture industry and farmers are angry about competition from Europe in the wake of a separate trade agreement between their country and the EU. Canada and other dairy-exporting nations, including the US, were not eager to agree to provisions opening their markets without reassurance that a comprehensive deal was at hand.
Despite the divisions over politically charged issues, what has kept the trade ministers going is the knowledge of how much they have agreed to tentatively.
A final agreement would include 30 chapters covering different trade sectors and subjects and all but two of those — the ones that would include the terms of market access for dairy exports and intellectual property protections for pharmaceutical drugs — are all but finished.
However, as trade negotiators like to say, nothing is agreed to until everything is agreed to.
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has appointed Rose Castanares, executive vice president of TSMC Arizona, as president of the subsidiary, which is responsible for carrying out massive investments by the Taiwanese tech giant in the US state, the company said in a statement yesterday. Castanares will succeed Brian Harrison as president of the Arizona subsidiary on Oct. 1 after the incumbent president steps down from the position with a transfer to the Arizona CEO office to serve as an advisor to TSMC Arizona’s chairman, the statement said. According to TSMC, Harrison is scheduled to retire on Dec. 31. Castanares joined TSMC in
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the